XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenue $ 9,487 $ 8,306
Cost of revenue 5,103 4,177
Gross profit 4,384 4,129
Operating expenses:    
Research and development 5,398 3,905
Selling, general and administrative 12,003 9,745
Total operating expenses 17,401 13,650
Loss from operations (13,017) (9,521)
Other income:    
Interest income 1,017 171
Interest expense (551) (20)
Other income (expense), net 19 (45)
Total other income, net 485 106
Net loss $ (12,532) $ (9,415)
Net loss per share, basic $ (0.39) $ (0.30)
Net loss per share, diluted $ (0.39) $ (0.30)
Weighted average common shares outstanding, basic 31,965,799 31,210,567
Weighted average common shares outstanding, diluted 31,965,799 31,210,567
Product revenue    
Revenue $ 7,022 $ 6,508
Cost of revenue 3,786 2,972
Service revenue    
Revenue 2,240 1,521
Cost of revenue 1,270 1,069
Contract revenue    
Revenue 225 277
Cost of revenue $ 47 $ 136